Huddersfield based pharmaceutical manufacturer, Thornton & Ross has been announced as a finalist in three categories of the Communiqué Awards 2020, for educational content produced by its brands, Flexitol® and Fultium®-D3.
Part of the German-based STADA group, Thornton & Ross develops, manufactures and supplies a wide range of branded products, including Fultium®-D3, used for the prevention and treatment of Vitamin D deficiency.
The brand’s ‘Getting Vitamin D Right From The Start’ conference and MIAB development has been shortlisted in the ‘Education Meetings/Stand-Alone Events’ category of the Communiqué Awards, as well as being nominated for the ‘Professional Education Programmes Award’ for its MIMS vitamin D module and diagnostic toolkit offering.
Thornton & Ross’ leading foot skincare brand, Flexitol® has also been shortlisted - in the ‘Excellence in Patient Programmes’ category. This follows the success of its Simple Steps campaign, which strives to raise awareness and provide materials to help people with diabetes take control of their foot health.
Tim Brady, Executive Sales & Marketing Director of Thornton & Ross, praised the team in response to the company’s latest achievement:
“I’m delighted that two of our brands have been shortlisted for these incredibly prestigious awards. The Flexitol and Fultium content provides excellent tools for industry professionals as well as consumers, so we’re confident about being in with a chance of bringing home first prize. This latest success is a deserving tribute to the innovative, inspiring team at Thornton & Ross.”
Designed to recognise and commend excellence and best practice in European, international and local healthcare communications, the Communiqué Awards 2020 champions high standards and helps to shape future thinking. A panel of judges will select the winners ahead of the announcement on 2nd July 2020.